Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002244215 | SCV002512594 | uncertain significance | PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome | 2021-08-17 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2 moderate, BP4 supporting |
Revvity Omics, |
RCV002244215 | SCV003812842 | uncertain significance | PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome | 2019-05-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734480 | SCV005357613 | uncertain significance | PHIP-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | The PHIP c.4546G>A variant is predicted to result in the amino acid substitution p.Val1516Ile. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |